Emirates Pharmaceuticals highlights regulatory expertise
The Emirates Pharmaceutical Manufacturing Company participated in the GCORAS 2026 Summit in Seoul, where it showcased its experience in pharmaceutical regulation and healthcare sector development. It also announced its joining of a global regulatory collaboration platform to enhance communication and facilitate the exchange of international expertise. Additionally, the company explored ways to expand cooperation with the Korean side, including medical technology, research and development, and regulation, with the Koreans welcoming the exploration of opportunities in the Emirati market as part of strengthening the UAE’s position as a regional and international hub for the pharmaceutical industry.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)